A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia

NCT02412917 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

237

Enrollment

INDUSTRY

Sponsor class

Conditions

Shingles
Herpes Zoster
Postherpetic Neuralgia

Interventions

DRUG: FV-100
DRUG: valacyclovir

Sponsor

ContraVir Pharmaceuticals, Inc.